TransEnterix submitted the FDA request for additional information to receive clearance for the company’s Senhance Surgical Robotic System.
Here are five insights:
1. Senhance Surgical Robotic System is a multiport robotic system designed to give surgeons haptic feedback, eye sensing camera control and other innovative technology services.
2. While the surgical robotic system received the CE mark in Europe, the company is in the process of receiving FDA clearance to market in the U.S.
3. TransEnterix is a medical device company that develops robotics to improve minimally invasive surgery by addressing clinical and economic challenges associated with current
laparoscopic and robotic options.
4. The company also developed the SurgiBot System, a single-port, robotically enhanced laparoscopic surgical platform.
5. TransEnterix expects to receive FDA clearance by the end of the year.
More articles on devices and implants:
Dr. Asif Ilyas completes 1st surgery using Globus Medical's trauma fixation system: 5 takeaways
NuVasive, DePuy Synthes, Zimmer Biomet & more: 10 device company notes
Dr. Steven Yang performs 1st Freedom Lumbar Disc implant in Australia: 5 observations